Literature DB >> 9122041

Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP.

W J Wasilenko1, J Cooper, A J Palad, K D Somers, P F Blackmore, J S Rhim, G L Wright, P F Schellhammer.   

Abstract

BACKGROUND: Cellular calcium is an important second messenger for growth regulation. We sought to identify potentially important receptors on prostate tumor cells by screening over 20 agonists for their ability to increase intracellular free calcium ([Ca2+]i) in several human prostate tumor cell lines.
METHODS: Intracellular calcium mobilization was detected using fura-2.
RESULTS: We found bombesin, GRP, ATP/UTP, lysophosphatidic acid, thrombin, endothelin, histamine, and bradykinin increased [Ca2+]i in the advanced tumor cell lines DU-145, PC3, and PPC-1. Bombesin failed to elevate [Ca2+]i in an immortalized human prostate cell line. Rank-order of potency studies suggested the presence of P2U nucleotide receptors for ATP/UTP on prostate epithelial cells. Potency studies also revealed GRP > > bombesin > > neuromedin B at elevating [Ca2+]i in responding tumor cells.
CONCLUSIONS: These findings indicate that androgen independent prostate tumor cell lines express multiple receptors capable of elevating intracellular calcium, and suggest that GRP receptors may be selectively expressed and/or coupled to calcium signaling during prostate tumor progression. Calcium sensitive cellular events may therefore contribute to the progression of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122041     DOI: 10.1002/(sici)1097-0045(19970215)30:3<167::aid-pros4>3.0.co;2-j

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.

Authors:  R Janssens; J M Boeynaems
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 4.  Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).

Authors:  S Ventura; V l Oliver; C W White; J H Xie; J M Haynes; B Exintaris
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 5.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

6.  Effects of adenine nucleosides and nucleotides on neuromuscular transmission to the prostatic stroma of the rat.

Authors:  A Preston; W A Lau; J N Pennefather; S Ventura
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

7.  Adenosine 5'-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland.

Authors:  Sabatino Ventura; Ramila K Dewalagama; Linda C L Lau
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

9.  Expression of functional protease-activated receptor 1 in human prostate cancer cell lines.

Authors:  Jian Liu; Manuela Bastian; Peter Kohlschein; Peter Schuff-Werner; Michael Steiner
Journal:  Urol Res       Date:  2003-03-25

10.  Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.

Authors:  Xiaodong Wen; Celia Chao; Kirk Ives; Mark R Hellmich
Journal:  BMC Mol Biol       Date:  2011-07-11       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.